(Press-News.org) An assessment published this week in the journal The Lancet HIV provides new insight about an initiative to integrate treatment of opioid use disorder along with HIV in Vietnam.
The study marks one of the first scientifically robust assessments of a new model of treating HIV in lower or middle income countries where injection drug use is a major cause of HIV infection. It also suggests the importance of building support for peer and community connections to tackle the opioid epidemic that continues to ravage the United States in the midst of the COVID-19 pandemic.
The study was led by scientists and physicians at Hanoi Medical University and Oregon Health & Science University.
"Our study suggests that countries that want to expand treatment for opioid use disorder with buprenorphine should consider interventions to support retention on treatment directed at family networks, peers and community health workers," said co-author Todd Korthuis, M.D., M.P.H., a leader in addiction medicine at OHSU and the study's principal investigator.
Korthuis, professor of medicine (general internal medicine and geriatrics) in the OHSU School of Medicine, became involved in initiating the program in Vietnam after serving as a Visiting Fulbright Scholar in 2012-13.
The new study is the first multisite randomized trial to compare HIV clinic-based buprenorphine therapy compared with simply referring HIV patients to methadone clinics for opioid use disorder treatment. The study examined outcomes for opioid use disorder and for HIV, and how well participants stuck with treatment.
Researchers found that ongoing support is critical.
"We understand that addiction is a brain disease, so people have relapses," senior author Le Minh Giang, M.D., Ph.D., chair of global health at Hanoi Medical University, said in a podcast hosted by The Lancet HIV. "In many cases, the patients left the opioid use disorder treatment and then relapsed into drug use. That's problematic for people who don't have good support from clinical staff."
Buprenorphine, also known as Suboxone, can be prescribed and used outside a specialty addiction clinic, whereas methadone must be closely monitored in part because of a higher risk of overdose in unsupervised settings. Between July of 2015 and February of 2018, a total of 281 people were enrolled in a pilot project to treat people with buprenorphine - a first in Vietnam.
"It's a more flexible treatment than methadone maintenance," Korthuis said. "You can integrate it into HIV clinics and, theoretically, in primary care clinics. Methadone has to be very carefully controlled in a specialty setting."
The new study found that access to buprenorphine is essential for countries aiming to expand access to treatment for opioid use disorder, especially among patients also being treated for HIV.
"One of the things I was impressed with, is the very tight social fabric in Vietnam," Korthuis said in the Lancet podcast. "It's impossible not to overstate the role of the family, the role of the neighborhood and the role of the community in every aspect of life, including health care."
In fact, Korthuis is already implementing a similar outreach model in several rural counties in Oregon through an initiative funded by the National Institutes of Health. Known as Oregon HIV/Hepatitis and Opioid Prevention and Engagement, or Oregon HOPE, the initiative relies on peers who have recovered from addiction to engage their neighbors in prevention and treatment services.
The program is currently active in several counties across southern and eastern Oregon.
"Community health workers who really know their neighborhoods are really good at engaging people in addiction treatment - and keeping them in treatment," Korthuis said.
INFORMATION:
The Oregon HOPE project now includes Lane, Douglas, Josephine, Curry, Coos, part of Jackson and Umatilla counties in Oregon.
The research was supported through grants from the NIH National Institute on Drug Abuse, awards R01DA037441 and UG1DA015815; and NIH National Center of Advancing Translational Sciences award UL1TR002369.
WOODS HOLE, Mass. -- Egg cells start out as round blobs. After fertilization, they begin transforming into people, dogs, fish, or other animals by orienting head to tail, back to belly, and left to right. Exactly what sets these body orientation directions has been guessed at but not seen. Now researchers at the Marine Biological Laboratory (MBL) have imaged the very beginning of this cellular rearrangement, and their findings help answer a fundamental question.
"The most interesting and mysterious part of developmental biology is the origin of the body axis in animals," said researcher Tomomi Tani. An MBL scientist in the Eugene Bell Center at the time of the research, Tani is now with Japan's National Institute of Advanced Industrial Science and Technology.
The work by Tani and ...
CHAMPAIGN, Ill. -- Chemical manufacturers frequently use toxic solvents such as alcohols and benzene to make products like pharmaceuticals and plastics. Researchers are examining a previously overlooked and misunderstood phenomenon in the chemical reactions used to make these products. This discovery brings a new fundamental understanding of catalytic chemistry and a steppingstone to practical applications that could someday make chemical manufacturing less wasteful and more environmentally sound.
The study led by University of Illinois Urbana-Champaign researcher David Flaherty, University of Minnesota, Twin Cities researcher Matthew Neurock and Virginia Tech researcher Ayman Karim is published in the journal Science.
Combining ...
For more than a century, optical coatings have been used to better reflect certain wavelengths of light from lenses and other devices or, conversely, to better transmit certain wavelengths through them. For example, the coatings on tinted eyeglasses reflect, or "block out," harmful blue light and ultraviolet rays.
But until now, no optical coating had ever been developed that could simultaneously reflect and transmit the same wavelength, or color.
In a paper in Nature Nanotechnology, researchers at the University of Rochester and Case Western Reserve University describe a new class of optical coatings, so-called Fano Resonance Optical Coatings (FROCs), that can be used on filters to reflect and transmit colors of remarkable purity.
In addition, ...
The rapid development of silicon-based transistors leads to its integration getting closer to the limit of Moore's law. Graphene is expected to become the next generation of mainstream chip materials due to its ultra-high carrier mobility. However, it is difficult to obtain a high on/off current ratio for intrinsic graphene-based transistor owing to the absence of bandgap. Graphene nanoribbons, which possess a tunable bandgap and unique optoelectrical properties, have attracted extensive attention and exploration.
Nowadays, the preparation of graphene nanoribbons is underdeveloped, and common strategies include the clip of carbon materials (graphene films, carbon nanotubes, or graphite) ...
When we think about the links to the future - the global transition to solar and wind energy, tactile virtual reality or synthetic neurons - there's no shortage of big ideas. It's the materials to execute the big ideas - the ability to manufacture the lithium-ion batteries, opto-electronics and hydrogen fuel cells - that stand between concept and reality.
Enter two-dimensional materials, the latest step in innovation. Consisting of a single layer of atoms, two-dimensional materials like graphene and phosphorene exhibit new properties with far-reaching potential. With a capability to be combined like Lego bricks, these materials ...
CLEVELAND--Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers that could tell doctors which lung cancer patients might actually get worse from immunotherapy.
Until recently, researchers and oncologists had placed these lung cancer patients into two broad categories: those who would benefit from immunotherapy, and those who likely would not.
But a third category--patients called hyper-progressors who would actually be harmed by immunotherapy, including a shortened lifespan after treatment--has begun ...
PITTSBURGH, Feb. 4, 2021 - Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy--which has a failure rate of 40% for this type of cancer--into patients who do.
The results of this proof-of-principle phase II clinical trial were published online today in Science. In this study, a team of researchers from UPMC Hillman administered fecal microbiota transplants (FMT) and anti-PD-1 immunotherapy to melanoma patients ...
Despite living in the same part of the Mojave Desert, and experiencing similar conditions, mammals and birds native to this region experienced fundamentally different exposures to climate warming over the last 100 years, a new study shows; small mammal communities there remained much more stable than birds, in the face of local climate change, it reports. The study presents an integrative approach to understanding the climate vulnerability of biodiversity in rapidly warming regions. Exposure to rising temperature extremes threatens species worldwide. It is expected to push many ever closer toward extinction. Thus, understanding ...
The soundscapes of the Anthropocene ocean are fundamentally different from those of pre-industrial times, becoming more and more a raucous cacophony as the noise from human activity has grown louder and more prevalent. In a Review, Carlos Duarte and colleagues show how the rapidly changing soundscape of modern oceans impacts marine life worldwide. According to the authors, mitigating these impacts is key to achieving a healthier ocean. From the plangent songs of cetaceans to grinding arctic sea ice, the world's oceans' natural chorus is performed by a vast ensemble of geological (geophony) and biological (biophony) sounds. However, for more than a century, ...
In February 2001, the first drafts of the human genome were published. In this Special Issue of Science, "Human Genome at 20," an Editorial, a Policy Forum, a series of NextGen Voices Letters and a Perspective explore the complicated legacy of the Human Genome Project (HGP). "Millions of people today have access to their personal genomic information, with direct-to-consumer services and integration with other 'big-data' increasingly commoditizing what was rightly celebrated as a singular achievement in February 2001," writes Science Senior Editor Brad Wible.
An Editorial by Claire Frasier, director of the Institute for Genome Sciences at the University ...
